臨床栄養の世界市場2020-2026:投与経路別(経口、経腸、非経口)、用途別、地域別

◆英語タイトル:Global Clinical Nutrition Market By Route of Administration (Oral, Enteral and Parenteral) By Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications) By Region, Industry Analysis and Forecast, 2020 - 2026
◆商品コード:KBV20OCT096
◆発行会社(リサーチ会社):KBV Research
◆発行日:2020年5月31日
◆ページ数:220
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ、カナダ、メキシコ、ロシア、ドイツ、イギリス、フランス、スペイン、イタリア、中国、日本、インド、韓国、シンガポール、マレーシア、ブラジル、アルゼンチン、アラブ首長国連邦、サウジアラビア、南アフリカ、ナイジェリア
◆販売価格オプション(消費税別)
Single User(1名様利用)USD3,600 ⇒換算¥388,800見積依頼/購入/質問フォーム
Global License(法人利用)USD6,048 ⇒換算¥653,184見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はKBV Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
KBV Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本市場調査レポートでは、臨床栄養の世界市場について、市場範囲・調査手法、市場概要、競争分析、投与経路別(経口、経腸、非経口)分析、用途別分析、エンドユーザー別分析、地域別分析、企業概要などを総合的、多面的に調査・分析しました。
・市場範囲・調査手法
・市場概要
・競争分析
・臨床栄養の世界市場規模:投与経路別(経口、経腸、非経口)
・臨床栄養の世界市場規模:用途別
・臨床栄養の世界市場規模:エンドユーザー別
・臨床栄養の世界市場規模:地域別
・企業概要
【レポートの概要】

The Global Clinical Nutrition Market size is expected to reach $44.7 billion by 2026, rising at a market growth of 6.9% CAGR during the forecast period. Clinical nutrition is a type of pharmaceutical product that keeps patients healthy with the necessary amounts of nutrients such as proteins, vitamins, and minerals. These nutritional components help to improve metabolic functions, release, and body absorption. Nutrition offers key nutrients, such as minerals, proteins, and vitamins. In addition, nutrition is an amalgamation of science and medicine that offers a wide range of nutrient medicines.

In treating the conditions associated with chronic diet malnutrition & treatments, clinical nutrition is being used extensively. Additionally, dietary improvements help people to get a correct diet and body balance. Clinical nutrition works in acute and ambulatory medical conditions including heart recovery, renal dialysis, diabetes, pediatrics, nutrition care, cancer, trauma, and treatments at wellness centers.

In most of the nations, it has also been shown that health spending tends to rise faster than economic growth, continuing a pattern that has been established across the decades. Subsequently, due to their broad applicability, the market is expected to grow higher as the spending in healthcare among the major countries of the world increases. Governments around the world, including private foundations and the international community, are offering many financial opportunities for clinical nutrition. National health institutes, the U.S Department of Agriculture, the Robert Woods Johnson Foundation, and the Nestle Foundation are major financing organizations.

Recent years have seen a high focus among businesses and clinics on fitness and wellness, aging, and disease prevention. In the presence of a variety of chronic disorders, such as coronary heart disease, ischemic stroke, diabetes, and some cancer indications, preventive medical treatment is successful and has been widely embraced by hospitals and clinics in North America. Furthermore, health expenditure continues to grow faster than economic growth in most countries. The emergence of fair, responsive, and efficient health services throughout North American countries has also led to the highest share of GDP for healthcare spending.

Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The major strategies followed by the market participants are Acquisition and Product Launches. Based on the Analysis presented in the Cardinal matrix, BASF SE, Pfizer, Inc., Nestle S.A., and Abbott Laboratories are the forerunners in the Clinical Nutrition Market. Companies such as Lonza Group AG, Ajinomoto Co., Inc., B. Braun Melsungen AG, Baxter International, Inc., and Perrigo Company PLC are some of the key innovators in the market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.

Recent strategies deployed in Clinical Nutrition Market
Partnerships, Collaborations, and Agreements:

Dec-2019: BASF Nutrition & Health announced its collaboration with Idogen, a Swiss pharmaceutical company. Following the collaboration, the former company launched an omega 3 fatty acid solution, Hepacor, in the European market. The solution helps patients manage Non-Alcoholic Fatty Liver Disease (NAFLD) by elevating healthy lipids in the bloodstream.
Sep-2019: B. Braun collaborated with Smartfish AS, a nutrition-based company. The collaboration was focused on securely launching the latter company’s medical nutrition product Remune.
May-2019: Nestle Health Science came into partnership with Amazentis, a pioneer in science-driven nutritional health. The partnership was focused on developing its new cellular nutrient Urolithin A. Also, the two companies were aimed to conduct a joint research program for expanding applications of Urolithin A, a pioneering cellular nutrient that supports mitochondrial health into new consumer health and medical areas.
May-2019: BASF partnered with Glycosyn, a biotechnology company. The partnership was aimed to develop and commercialize human milk oligosaccharides (HMOs) for broad use in dietary supplements, functional nutrition, and medical food.
Feb-2019: Lonza Consumer Health & Nutrition teamed up with DuPont Nutrition & Health. Following the collaboration, the companies were aimed to manufacture and supply human milk oligosaccharides (HMO).
Feb-2019: Ajinomoto’s subsidiary Cambrooke Therapeutics signed partnership agreement with Trovita Health Science, a specialty medical nutrition company. The partnership was focused on joint marketing and development of ENU Nutrition meal replacement shakes.
Acquisition and Mergers:
Nov-2017: Ajinomoto Co., Inc. announced the acquisition of Cambrooke Therapeutics, Inc., a global leader and innovator in therapeutic nutrition for inborn errors of metabolism and ketogenic diet therapy. With this acquisition, Cambrooke got access to Ajinomoto’s global nutrition and ingredient sciences expertise, as well as proven flavor and texture-enhancing R&D capabilities.
Jul-2017: Lonza Group took over Capsugel S.A. from KKR. The acquisition accelerated the company’s existing product offerings and enabled the company to strengthen its business in the pharma and consumer healthcare and nutrition industries.
Jan-2017: Abbott acquired St. Jude Medical, Inc., a medical device company. The acquisition expanded opportunities for Abbott’s future growth and helped the company in developing a strong, diverse portfolio of devices, diagnostics, nutrition, and branded generic pharmaceuticals.
Sep-2016: Lonza acquired Benicia, a CA-based InterHealth Nutraceuticals, nutritional ingredient research, development, and manufacture company. The acquisition broadened Lonza’s nutritional ingredient portfolio and strengthened its position in the dietary supplement market.
Jan-2016: Pfizer completed the acquisition of Sirio Pharma’s wholly-owned subsidiary, Treerly Health Co., a women’s nutritional healthcare brand in China. The acquisition broadened Pfizer Consumer Healthcare’s products in China with OTC dietary supplements.
Product Launches and Product Expansions:
Oct-2019: Lonza launched MuscleGuard formulation, a unique patent-pending ingredient combination. The combination comprised of a precise and clinically-studied ratio of four nutrients; Lonza’s Carnipure L-Carnitine, Creatine, and Leucine with vitamin D. MuscleGuard formulation deliver positive results for sports performance and recovery through a significant increase in muscle strength, mass, and activity.
Aug-2019: Baxter International introduced the Olimel N12, the new addition to the company’s olive oil-based parenteral nutrition (PN) triple-chamber bag portfolio. Olimel N12 combined a high protein formulation with low glucose content, resulting in the lowest energy to protein ratio currently available in a standardized, triple-chamber bag.
Jul-2019: Baxter International announced the European launch of Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN). Finomel offers healthcare providers with additional options to meet adult patients’ diverse nutritional needs.

Scope of the Study
Market Segmentation:

By Route of Administration
• Oral
• Enteral and
• Parenteral

By Application
• Cancer
• Neurological Diseases
• Gastrointestinal Disorders
• Metabolic Disorders and
• Other Applications

By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA

Companies Profiled
• Abbott Laboratories
• B. Braun Melsungen AG
• Baxter International, Inc.
• Pfizer, Inc.
• Nestle S.A.
• Lonza Group AG
• BASF SE
• Ajinomoto Co., Inc.
• Perrigo Company PLC
• Hero Nutritionals, Inc.

Unique Offerings from KBV Research
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

【レポートの目次】

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Clinical Nutrition Market, by Route of Administration
1.4.2 Global Clinical Nutrition Market, by Application
1.4.3 Global Clinical Nutrition Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis – Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Jan – 2019, Dec) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2016, Mar – 2019, Oct) Leading Players
Chapter 4. Global Clinical Nutrition Market by Route Of Administration
4.1 Global Oral Market by Region
4.2 Global Enteral Market by Region
4.3 Global Parenteral Market by Region
Chapter 5. Global Clinical Nutrition Market by Application
5.1 Global Cancer Market by Region
5.2 Global Neurological Diseases Market by Region
5.3 Global Gastrointestinal Disorders Market by Region
5.4 Global Metabolic Disorders Market by Region
5.5 Global Other Applications Market by Region
Chapter 6. Global Clinical Nutrition Market by End User
6.1 Global Adults Clinical Nutrition Market by Region
6.2 Global Pediatric Market by Region
6.3 Global Geriatric Market by Region
Chapter 7. Global Clinical Nutrition Market by Region
7.1 North America Clinical Nutrition Market
7.1.1 North America Clinical Nutrition Market by Route Of Administration
7.1.1.1 North America Oral Market by Country
7.1.1.2 North America Enteral Market by Country
7.1.1.3 North America Parenteral Market by Country
7.1.2 North America Clinical Nutrition Market by Application
7.1.2.1 North America Cancer Market by Country
7.1.2.2 North America Neurological Diseases Market by Country
7.1.2.3 North America Gastrointestinal Disorders Market by Country
7.1.2.4 North America Metabolic Disorders Market by Country
7.1.2.5 North America Other Applications Market by Country
7.1.3 North America Clinical Nutrition Market by End User
7.1.3.1 North America Adults Clinical Nutrition Market by Country
7.1.3.2 North America Pediatric Market by Country
7.1.3.3 North America Geriatric Market by Country
7.1.4 North America Clinical Nutrition Market by Country
7.1.4.1 US Clinical Nutrition Market
7.1.4.1.1 US Clinical Nutrition Market by Route Of Administration
7.1.4.1.2 US Clinical Nutrition Market by Application
7.1.4.1.3 US Clinical Nutrition Market by End User
7.1.4.2 Canada Clinical Nutrition Market
7.1.4.2.1 Canada Clinical Nutrition Market by Route Of Administration
7.1.4.2.2 Canada Clinical Nutrition Market by Application
7.1.4.2.3 Canada Clinical Nutrition Market by End User
7.1.4.3 Mexico Clinical Nutrition Market
7.1.4.3.1 Mexico Clinical Nutrition Market by Route Of Administration
7.1.4.3.2 Mexico Clinical Nutrition Market by Application
7.1.4.3.3 Mexico Clinical Nutrition Market by End User
7.1.4.4 Rest of North America Clinical Nutrition Market
7.1.4.4.1 Rest of North America Clinical Nutrition Market by Route Of Administration
7.1.4.4.2 Rest of North America Clinical Nutrition Market by Application
7.1.4.4.3 Rest of North America Clinical Nutrition Market by End User
7.2 Europe Clinical Nutrition Market
7.2.1 Europe Clinical Nutrition Market by Route Of Administration
7.2.1.1 Europe Oral Market by Country
7.2.1.2 Europe Enteral Market by Country
7.2.1.3 Europe Parenteral Market by Country
7.2.2 Europe Clinical Nutrition Market by Application
7.2.2.1 Europe Cancer Market by Country
7.2.2.2 Europe Neurological Diseases Market by Country
7.2.2.3 Europe Gastrointestinal Disorders Market by Country
7.2.2.4 Europe Metabolic Disorders Market by Country
7.2.2.5 Europe Other Applications Market by Country
7.2.3 Europe Clinical Nutrition Market by End User
7.2.3.1 Europe Adults Clinical Nutrition Market by Country
7.2.3.2 Europe Pediatric Market by Country
7.2.3.3 Europe Geriatric Market by Country
7.2.4 Europe Clinical Nutrition Market by Country
7.2.4.1 Germany Clinical Nutrition Market
7.2.4.1.1 Germany Clinical Nutrition Market by Route Of Administration
7.2.4.1.2 Germany Clinical Nutrition Market by Application
7.2.4.1.3 Germany Clinical Nutrition Market by End User
7.2.4.2 UK Clinical Nutrition Market
7.2.4.2.1 UK Clinical Nutrition Market by Route Of Administration
7.2.4.2.2 UK Clinical Nutrition Market by Application
7.2.4.2.3 UK Clinical Nutrition Market by End User
7.2.4.3 France Clinical Nutrition Market
7.2.4.3.1 France Clinical Nutrition Market by Route Of Administration
7.2.4.3.2 France Clinical Nutrition Market by Application
7.2.4.3.3 France Clinical Nutrition Market by End User
7.2.4.4 Russia Clinical Nutrition Market
7.2.4.4.1 Russia Clinical Nutrition Market by Route Of Administration
7.2.4.4.2 Russia Clinical Nutrition Market by Application
7.2.4.4.3 Russia Clinical Nutrition Market by End User
7.2.4.5 Spain Clinical Nutrition Market
7.2.4.5.1 Spain Clinical Nutrition Market by Route Of Administration
7.2.4.5.2 Spain Clinical Nutrition Market by Application
7.2.4.5.3 Spain Clinical Nutrition Market by End User
7.2.4.6 Italy Clinical Nutrition Market
7.2.4.6.1 Italy Clinical Nutrition Market by Route Of Administration
7.2.4.6.2 Italy Clinical Nutrition Market by Application
7.2.4.6.3 Italy Clinical Nutrition Market by End User
7.2.4.7 Rest of Europe Clinical Nutrition Market
7.2.4.7.1 Rest of Europe Clinical Nutrition Market by Route Of Administration
7.2.4.7.2 Rest of Europe Clinical Nutrition Market by Application
7.2.4.7.3 Rest of Europe Clinical Nutrition Market by End User
7.3 Asia Pacific Clinical Nutrition Market
7.3.1 Asia Pacific Clinical Nutrition Market by Route Of Administration
7.3.1.1 Asia Pacific Oral Market by Country
7.3.1.2 Asia Pacific Enteral Market by Country
7.3.1.3 Asia Pacific Parenteral Market by Country
7.3.2 Asia Pacific Clinical Nutrition Market by Application
7.3.2.1 Asia Pacific Cancer Market by Country
7.3.2.2 Asia Pacific Neurological Diseases Market by Country
7.3.2.3 Asia Pacific Gastrointestinal Disorders Market by Country
7.3.2.4 Asia Pacific Metabolic Disorders Market by Country
7.3.2.5 Asia Pacific Other Applications Market by Country
7.3.3 Asia Pacific Clinical Nutrition Market by End User
7.3.3.1 Asia Pacific Pediatric Market by Country
7.3.3.2 Asia Pacific Geriatric Market by Country
7.3.4 Asia Pacific Clinical Nutrition Market by Country
7.3.4.1 China Clinical Nutrition Market
7.3.4.1.1 China Clinical Nutrition Market by Route Of Administration
7.3.4.1.2 China Clinical Nutrition Market by Application
7.3.4.1.3 China Clinical Nutrition Market by End User
7.3.4.2 Japan Clinical Nutrition Market
7.3.4.2.1 Japan Clinical Nutrition Market by Route Of Administration
7.3.4.2.2 Japan Clinical Nutrition Market by Application
7.3.4.2.3 Japan Clinical Nutrition Market by End User
7.3.4.3 India Clinical Nutrition Market
7.3.4.3.1 India Clinical Nutrition Market by Route Of Administration
7.3.4.3.2 India Clinical Nutrition Market by Application
7.3.4.3.3 India Clinical Nutrition Market by End User
7.3.4.4 South Korea Clinical Nutrition Market
7.3.4.4.1 South Korea Clinical Nutrition Market by Route Of Administration
7.3.4.4.2 South Korea Clinical Nutrition Market by Application
7.3.4.4.3 South Korea Clinical Nutrition Market by End User
7.3.4.5 Singapore Clinical Nutrition Market
7.3.4.5.1 Singapore Clinical Nutrition Market by Route Of Administration
7.3.4.5.2 Singapore Clinical Nutrition Market by Application
7.3.4.5.3 Singapore Clinical Nutrition Market by End User
7.3.4.6 Malaysia Clinical Nutrition Market
7.3.4.6.1 Malaysia Clinical Nutrition Market by Route Of Administration
7.3.4.6.2 Malaysia Clinical Nutrition Market by Application
7.3.4.6.3 Malaysia Clinical Nutrition Market by End User
7.3.4.7 Rest of Asia Pacific Clinical Nutrition Market
7.3.4.7.1 Rest of Asia Pacific Clinical Nutrition Market by Route Of Administration
7.3.4.7.2 Rest of Asia Pacific Clinical Nutrition Market by Application
7.3.4.7.3 Rest of Asia Pacific Clinical Nutrition Market by End User
7.4 LAMEA Clinical Nutrition Market
7.4.1 LAMEA Clinical Nutrition Market by Route Of Administration
7.4.1.1 LAMEA Oral Market by Country
7.4.1.2 LAMEA Enteral Market by Country
7.4.1.3 LAMEA Parenteral Market by Country
7.5 LAMEA Clinical Nutrition Market by Application
7.5.1.1 LAMEA Cancer Market by Country
7.5.1.2 LAMEA Neurological Diseases Market by Country
7.5.1.3 LAMEA Gastrointestinal Disorders Market by Country
7.5.1.4 LAMEA Metabolic Disorders Market by Country
7.5.1.5 LAMEA Other Applications Market by Country
7.5.2 LAMEA Clinical Nutrition Market by End User
7.5.2.1 LAMEA Adults Clinical Nutrition Market by Country
7.5.2.2 LAMEA Pediatric Market by Country
7.5.2.3 LAMEA Geriatric Market by Country
7.5.3 LAMEA Clinical Nutrition Market by Country
7.5.3.1 Brazil Clinical Nutrition Market
7.5.3.1.1 Brazil Clinical Nutrition Market by Route Of Administration
7.5.3.1.2 Brazil Clinical Nutrition Market by Application
7.5.3.1.3 Brazil Clinical Nutrition Market by End User
7.5.3.2 Argentina Clinical Nutrition Market
7.5.3.2.1 Argentina Clinical Nutrition Market by Route Of Administration
7.5.3.2.2 Argentina Clinical Nutrition Market by Application
7.5.3.2.3 Argentina Clinical Nutrition Market by End User
7.5.3.3 UAE Clinical Nutrition Market
7.5.3.3.1 UAE Clinical Nutrition Market by Route Of Administration
7.5.3.3.2 UAE Clinical Nutrition Market by Application
7.5.3.3.3 UAE Clinical Nutrition Market by End User
7.5.3.4 Saudi Arabia Clinical Nutrition Market
7.5.3.4.1 Saudi Arabia Clinical Nutrition Market by Route Of Administration
7.5.3.4.2 Saudi Arabia Clinical Nutrition Market by Application
7.5.3.4.3 Saudi Arabia Clinical Nutrition Market by End User
7.5.3.5 South Africa Clinical Nutrition Market
7.5.3.5.1 South Africa Clinical Nutrition Market by Route Of Administration
7.5.3.5.2 South Africa Clinical Nutrition Market by Application
7.5.3.5.3 South Africa Clinical Nutrition Market by End User
7.5.3.6 Nigeria Clinical Nutrition Market
7.5.3.6.1 Nigeria Clinical Nutrition Market by Application
7.5.3.6.2 Nigeria Clinical Nutrition Market by End User
7.5.3.7 Rest of LAMEA Clinical Nutrition Market
7.5.3.7.1 Rest of LAMEA Clinical Nutrition Market by Route Of Administration
7.5.3.7.2 Rest of LAMEA Clinical Nutrition Market by Application
7.5.3.7.3 Rest of LAMEA Clinical Nutrition Market by End User
Chapter 8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Partnerships, Collaborations, and Agreements:
8.3 Baxter International, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Product Launches and Product Expansions:
8.4 Pfizer, Inc.
8.4.1 Company Overview
8.4.2 Segmental and Regional Analysis
8.4.3 Research & Development Expense
8.4.4 Recent strategies and developments:
8.4.4.1 Acquisition and Mergers:
8.5 Nestle S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research& Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.5.3 Geographical Expansions:
8.6 Lonza Group AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.7 BASF SE
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Ajinomoto Co., Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental & Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Perrigo Company PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.1 Hero Nutritionals, Inc.
8.10.1 Company Overview



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臨床栄養の世界市場2020-2026:投与経路別(経口、経腸、非経口)、用途別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆